GENE ONLINE|News &
Opinion
Blog

2018-12-11| Interviews

The Hero Behind the scenes of the development of Japanese Regenerative Medicine – Japan Agency for Medical Research and Development (AMED)

by GeneOnline
Share To
Japan Agency for Medical Research and Development, AMED, was founded in April 2015 by Japanese government to engage in the field medical research and development (R&D). AMED’s main functions are to establish and sustain the environment for medical R&D, providing R&D funding, and managing frontier R&D projects. As Japanese government aims to improve the medical R&D in order to tackle the future challenge of super-aging society, AMED works completely beneath the Prime Minister’s Cabinet and national ministries, such as MEXT (the Ministries of Education, Culture, Sports, Science, and Technology), MHLW (the Ministry of Health, Labor and Welfare), or METI (the Ministry of Economy, Trade, and Industry), in Japan. In fact, the current tasks of AMED are based on the Healthcare Policy Act passed by the Cabinet, and according to the action plans proposed by Headquarters affiliated under the Prime Minister of Japan.

It's free! Log in now to read

LATEST
Flagship-Backed ProFound Launches With $75 Million to Discover Human Proteins
2022-05-27
Janssen’s First Cell Therapy Gets Europe’s Approval for Multiple Myeloma
2022-05-27
Cell and Gene Therapy Landscape in Japan is Moving Beyond Oncology
2022-05-27
New Study Reveals Hope for Recovery of Patients with Spinal Cord Injury
2022-05-27
Laekna Therapeutics Announces Dosing of First Patients in the U.S. and China in Phase Ib/III Study of Afuresertib in Combination with Fulvestrant in HR+/HER2- Breast Cancer
2022-05-26
Stanford Touts Remote-Controllable CAR-T Cell Therapy
2022-05-26
Phenomix Launches The First Obesity Biobank Registry To Study Underling Phenotypes
2022-05-26
EVENT
2022-06-03
ASCO Annual Meeting
Online and on-side
2022-06-07
Digital RESI June
Online
2022-06-09
Medhospafrica
Africa
2022-06-13
BIO International Convention
San Diego, CA
2022-12-14
BIOHK2022
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!